Back to Journals » Drug Design, Development and Therapy » Volume 9

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies

Total article views   Abstract views HTML views PDF downloads Totals
9,665 Dovepress* 6,579 1,798+ 1,847 8,377
PubMed Central* 0 1,288 578 1,288
Totals 6,579 3,086 2,425 9,665
*Since 20 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar